Treprostinil derivative compounds and methods of using same
US9776982B2 · kind B2 · utility
14Cited by
68References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2016 |
| Grant date | Oct 3, 2017 |
| Priority date | — |
| Expiry date | May 18, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.